PMID- 32053642 OWN - NLM STAT- MEDLINE DCOM- 20200603 LR - 20200603 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 15 IP - 2 DP - 2020 TI - Intake frequency of vegetables or seafoods negatively correlates with disease activity of rheumatoid arthritis. PG - e0228852 LID - 10.1371/journal.pone.0228852 [doi] LID - e0228852 AB - OBJECTIVE: To clarify the relationship between dietary habit and disease activity of rheumatoid arthritis (RA). METHODS: This study enrolled RA patients who met the ACR/EULAR 2010 classification criteria from Kyoto University Rheumatoid Arthritis Management Alliance (KURAMA) cohort in 2015. 22-item food frequency questionnaire (FFQ) was taken for the measurement of dietary habit in a single-institution cohort of RA (Kyoto University Rheumatoid Arthritis Management Alliance: KURAMA) in 2015. The disease activities of RA using the Disease Activity Score calculated based on the erythrocyte sedimentation rate (DAS28-ESR), Simplified Disease Activity Index (SDAI), Health Assessment Questionnaire (HAQ), and serum matrix metalloproteinase-3 (MMP-3) level, the use of disease-modifying anti-rheumatic drugs (DMARDs), disease duration, rheumatoid factor, anti-cyclic citrullinated antibody, and body mass index were also examined. All of them were combined and statistically analyzed. RESULTS: 441 RA patients (81% women; mean age 65 years; mean disease duration 15 years) were enrolled from the KURAMA cohort. Average Disease Activity Score-28 using the erythrocyte sedimentation rate (DAS28-ESR) was 2.7. Univariate analysis showed that intake frequency of vegetables had a statistically significant negative correlation with disease activity markers, such as DAS28-ESR (rho = -0.11, p<0.01), Simplified Disease Activity Index (SDAI) (rho = -0.16, p<0.001), matrix metalloproteinase-3 (MMP-3) (rho = -0.21, p<0.0001), and Health Assessment Questionnaire (HAQ) (rho = -0.13, p<0.01). Factor analysis with varimax rotation was done to simplify the relevance of disease activity to various food items. 22 foods were categorized into five dietary patterns: "seafoods", "vegetables/fruits", "meats/fried foods", "snacks", and "processed foods". The multivariate analysis adjusted for clinically significant confounders showed that "seafoods" had statistically significant negative correlations with DAS28-ESR (beta = -0.15, p<0.01), SDAI (beta = -0.18, p<0.001), MMP-3 (beta = -0.15, p<0.01), and HAQ (beta = -0.24, p<0.0001). "Vegetables/fruits" had statistically significant negative correlations with SDAI (beta = -0.11 p<0.05), MMP-3 (beta = -0.12, p<0.01), and HAQ (beta = -0.11, p<0.05). CONCLUSIONS: These results suggest that high intake frequency of vegetables/fruits and/or seafoods might correlate with low disease activity. FAU - Murakami, Isao AU - Murakami I AD - Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. FAU - Murakami, Kosaku AU - Murakami K AUID- ORCID: 0000-0001-5981-4648 AD - Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. FAU - Hashimoto, Motomu AU - Hashimoto M AD - Department of the Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan. FAU - Tanaka, Masao AU - Tanaka M AD - Department of the Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan. FAU - Ito, Hiromu AU - Ito H AD - Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. FAU - Fujii, Takao AU - Fujii T AD - Department of Rheumatology and Clinical Immunology, Wakayama Medical University, Wakayama, Japan. FAU - Torii, Mie AU - Torii M AD - Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan. FAU - Ikeda, Kaori AU - Ikeda K AD - Department of Diabetes, Endocrinology, and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan. FAU - Kuwabara, Akiko AU - Kuwabara A AD - Department of Clinical Nutrition, Faculty of Comprehensive Rehabilitation, Osaka Prefecture University, Osaka, Japan. FAU - Tanaka, Kiyoshi AU - Tanaka K AD - Department of Faculty of Nutrition, Kobe Gakuin University, Hyogo, Japan. FAU - Yoshida, Akiko AU - Yoshida A AD - Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. FAU - Akizuki, Shuji AU - Akizuki S AD - Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. FAU - Nakashima, Ran AU - Nakashima R AD - Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. FAU - Yoshifuji, Hajime AU - Yoshifuji H AD - Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. FAU - Ohmura, Koichiro AU - Ohmura K AD - Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. FAU - Usui, Takashi AU - Usui T AD - Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. FAU - Morita, Satoshi AU - Morita S AD - Depatment of Biomedical Statistics and Bioinformatics, Kyoto University, Kyoto, Japan. FAU - Mimori, Tsuneyo AU - Mimori T AD - Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20200213 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) SB - IM MH - Aged MH - Aged, 80 and over MH - Arthritis, Rheumatoid/*drug therapy/*metabolism MH - Blood Sedimentation/drug effects MH - Cohort Studies MH - Feeding Behavior/physiology MH - Female MH - Humans MH - Male MH - Matrix Metalloproteinase 3/analysis/blood MH - Middle Aged MH - Nutrients/*therapeutic use MH - Seafood/analysis MH - Severity of Illness Index MH - Vegetables/metabolism PMC - PMC7018088 COIS- I.M. has declared no conflicts of interests. K.M. has received speaking fees, and/or consulting fees from Eisai Co. Ltd. M.H. received research grant and/or speaker fee from Astellas, Eisai, Tanabe-Mitsubishi, and Brystol-Meyers. T. M. received research grants and/or speaking fees from Asahikasei Pharma Corp., Astellas Pharma Inc., AYUMI Pharmaceutical Corp., Bristol-Myers Squibb, Chugai Pharmaceutical Co, Ltd., Diaichi-Sankyo Co.,Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Mitsubishi-Tanabe Pharma Co., Pfizer Japan Inc., Sanofi K.K. and Takeda Pharmaceutical Co., Ltd.. These companies had no role in the design of the study, the collection or analysis of the data, the writing of the manuscript or decision to submit the manuscript for the publication. This does not alter our adherence to PLOS ONE policies on sharing data and materials. EDAT- 2020/02/14 06:00 MHDA- 2020/06/04 06:00 PMCR- 2020/02/13 CRDT- 2020/02/14 06:00 PHST- 2019/11/13 00:00 [received] PHST- 2020/01/23 00:00 [accepted] PHST- 2020/02/14 06:00 [entrez] PHST- 2020/02/14 06:00 [pubmed] PHST- 2020/06/04 06:00 [medline] PHST- 2020/02/13 00:00 [pmc-release] AID - PONE-D-19-31605 [pii] AID - 10.1371/journal.pone.0228852 [doi] PST - epublish SO - PLoS One. 2020 Feb 13;15(2):e0228852. doi: 10.1371/journal.pone.0228852. eCollection 2020.